Evolving Approaches for HCC in the Molecular Medicine Era

EP. 1: Optimizing Care for Patients With Hepatocellular Carcinoma

ByTargeted Oncology

November 5th 2020

EP. 2: Hepatocellular Carcinoma Risk Stratification and Therapy

ByTargeted Oncology

November 5th 2020

EP. 3: Testing for Targetable Mutations in Hepatocellular Carcinoma

ByTargeted Oncology

November 5th 2020

EP. 4: Targeting the VEGF Pathway in Hepatocellular Carcinoma

ByTargeted Oncology

November 5th 2020

EP. 5: HCC: VEGF TKI Data and Treatment Selection

ByTargeted Oncology

November 5th 2020

EP. 6: PD-1/PD-L1 Antibodies and VEGF Inhibitors in HCC

ByTargeted Oncology

November 5th 2020

EP. 7: Atezolizumab/Bevacizumab Data in Frontline HCC

ByTargeted Oncology

November 5th 2020

EP. 8: Atezolizumab/Bevacizumab for HCC: Toxicity Management

ByTargeted Oncology

November 5th 2020

EP. 9: Choosing Between VEGF TKIs for Frontline HCC Treatment

ByTargeted Oncology

November 5th 2020

EP. 10: HCC Treatment After Previous I/O Therapy

ByTargeted Oncology

November 5th 2020

EP. 11: Novel Combinations Under Study for HCC

ByTargeted Oncology

November 5th 2020

EP. 12: Exciting Targets Under Study in HCC

ByTargeted Oncology

November 5th 2020